Ojjaara Prices, Coupons, Copay Cards & Patient Assistance
Ojjaara (momelotinib) is a member of the multikinase inhibitors drug class and is commonly used for Myelofibrosis.
The cost for Ojjaara 100 mg oral tablet is around $30,146 for a supply of 30 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Ojjaara is available as a brand name drug only, a generic version is not yet available. View generic Ojjaara availability for more details.
Ojjaara prices
Oral Tablet
100 mg
Ojjaara oral tablet
from $30,145.76
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 | $1,004.86 | $30,145.76 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
150 mg
Ojjaara oral tablet
from $30,145.76
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 | $1,004.86 | $30,145.76 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
200 mg
Ojjaara oral tablet
from $30,145.76
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 | $1,004.86 | $30,145.76 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Ojjaara Coupons, Copay Cards and Rebates
Ojjaara offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Ojjaara Together with GSK Oncology Co-pay Program
Eligible commercially insured patients may pay $0 per treatment with a maximum annual savings of $26,000 per eligibility period.
- Applies to:
- Ojjaara
- Number of uses:
- per eligibility period
Form more information phone: 844-447-5662 or Visit website
Ojjaara Quick Start Program
Eligible commercially insured experiencing a coverage delay at first dispense may receive a 30-day supply for FREE; for more information contact the program at 844-447-5662.
- Applies to:
- Ojjaara
- Number of uses:
- Temporary Assistance
Form more information phone: 844-447-5662 or Visit website
Ojjaara Bridge Program
Eligible commercially insured experiencing coverage interruptions while already on treatment may receive a 30-day supply for FREE; for more information contact the program at 844-447-5662.
- Applies to:
- Ojjaara
- Number of uses:
- Temporary Assistance
Form more information phone: 844-447-5662 or Visit website
Patient Assistance & Copay Programs for Ojjaara
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Ojjaara (momelotinib) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: Together with GSK Oncology
Eligibility requirements:- Determined case by case
- At or below 400% of FPL
- Medically appropriate condition/diagnosis
- Must reside in the US, DC, Puerto Rico or the USVI
- This program provides copay assistance. Contact the program for more detail. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Ojjaara (momelotinib) Tablet
More information please phone: 844-447-5662 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Ojjaara (momelotinib)
- Check interactions
- Compare alternatives
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español